PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for patients with migraine, C...
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that its groundbreaki...
LIXTE Biotechnology Holdings, Inc. announced the dosing of the first patient in a new clinical trial in collaboration with the Netherlands Cancer In...
Indian Union Cabinet, chaired by Prime Minister Shri Narendra Modi, recently approved the BioE3 (Biotechnology for Economy, Environment, and Empl...
Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. I...
Mpox is an infectious disease spread through close contact with contagious individuals or infected animals. Most people recover fully, but in some ...
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) te...
Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management of female pelvic di...
Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease ...
Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers f...
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicit...
Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing in...
Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, today announced a reorganization to best support the company as...
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...
© 2025 Biopharma Boardroom. All Rights Reserved.
